首页> 外文期刊>Journal of Pediatric Surgery Case Reports >Chylous ascites in an infant – Treated surgically with fibrin glue after failed medical treatment - A case report
【24h】

Chylous ascites in an infant – Treated surgically with fibrin glue after failed medical treatment - A case report

机译:婴儿的乳糜性腹水–治疗失败后用纤维蛋白胶进行手术治疗-病例报告

获取原文
       

摘要

Congenital chylous ascites (CCA) is a rare disease that results from mal development of the intra-abdominal lymphatic system and no gold standard treatment described so far. It is defined as the accumulation of triglyceride-rich milky fluid into peritoneal cavity in infant younger than three months. Medium chain triglyceride (MCT)-based diet or total parental nutrition (TPN) with rest to bowel and abdominal paracentesis is the time honoured conservative management. Due to rare incidence of this disorder, the existing literature includes mainly case reports where TPN was used with or without MCT based formulas along with octreotide. This condition is often refractory to therapy and is responsible for serious malnutrition and immunological deficiency because of loss of proteins and lymphocytes. Its treatment is often frustrating and challenge to physician. We report an infant with chylous ascites which was refractory to medical treatment in the form of prolonged bowel rest with TPN, Octreotide and repeated paracentesis. Surgical treatment with application of fibrin glue in the area of paradudenal retroperitoneal lymphatics sealed the lymphatic leak and cured the patient.
机译:先天性乳突性腹水(CCA)是一种罕见的疾病,是由于腹腔内淋巴系统异常发育而导致的,迄今为止尚无金标准治疗方法。它定义为三个月以下的婴儿中富含甘油三酸酯的乳状液向腹膜腔的积聚。基于中链甘油三酸酯(MCT)的饮食或总父母营养(TPN)以及肠和腹腔穿刺的休息时间是保守治疗的时间。由于这种疾病的罕见发生,现有文献主要包括病例报告,其中TPN与奥曲肽一起使用或不使用基于MCT的配方。这种疾病通常难以治疗,并且由于蛋白质和淋巴细胞的丢失而导致严重的营养不良和免疫缺陷。它的治疗常常令人沮丧,并给医生带来挑战。我们报告了婴儿乳糜性腹水,其对TPN,奥曲肽和反复穿刺穿刺术的长期肠道休息形式难以接受药物治疗。在腹膜后腹膜后淋巴管区域使用纤维蛋白胶的外科手术治疗可密封淋巴管漏出并治愈患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号